Clusterin in Alzheimer's disease: mechanisms, genetics, and lessons from other pathologies
EM Foster, A Dangla-Valls, S Lovestone… - Frontiers in …, 2019 - frontiersin.org
Clusterin (CLU) or APOJ is a multifunctional glycoprotein that has been implicated in several
physiological and pathological states, including Alzheimer's disease (AD). With a prominent …
physiological and pathological states, including Alzheimer's disease (AD). With a prominent …
HDL proteome and Alzheimer's disease: evidence of a link
Several lines of epidemiological evidence link increased levels of high-density lipoprotein-
cholesterol (HDL-C) with lower risk of Alzheimer's disease (AD). This observed relationship …
cholesterol (HDL-C) with lower risk of Alzheimer's disease (AD). This observed relationship …
Personalized immunotherapy against several neuronal and brain tumors
S Kuttruff-coqui, T Weinschenk, J Fritsche… - US Patent …, 2021 - Google Patents
2014-11-12 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases
Several isoforms of apolipoprotein J/clusterin (CLU) are encoded from a single gene located
on chromosome 8 in humans. These isoforms are ubiquitously expressed in the tissues, and …
on chromosome 8 in humans. These isoforms are ubiquitously expressed in the tissues, and …
The role and function of CLU in cancer biology and therapy
Y Zhang, X Lv, L Chen, Y Liu - Clinical and experimental medicine, 2023 - Springer
Clusterin (CLU) is a highly evolutionary conserved glycoprotein with multiple isoform-
specific functions and is widely distributed in different species. Accumulated evidence has …
specific functions and is widely distributed in different species. Accumulated evidence has …
The CLU-files: disentanglement of a mystery
P Rohne, H Prochnow, C Koch-Brandt - Biomolecular concepts, 2016 - degruyter.com
The multifaceted protein clusterin (CLU) has been challenging researchers for more than 35
years. The characterization of CLU as a molecular chaperone was one of the major …
years. The characterization of CLU as a molecular chaperone was one of the major …
GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer
N Li, A Zoubeidi, E Beraldi, ME Gleave - Oncogene, 2013 - nature.com
Expression of clusterin (CLU) closely correlates with the regulation of apoptosis in cancer.
Although endoplasmic reticulum (ER) stress-induced upregulation and retrotranslocation of …
Although endoplasmic reticulum (ER) stress-induced upregulation and retrotranslocation of …
The Pigmentation of Blue Light Is Mediated by Both Melanogenesis Activation and Autophagy Inhibition through OPN3–TRPV1
E Yu, SW Oh, SH Park, K Kwon, SB Han… - Journal of Investigative …, 2024 - Elsevier
Blue light, a high-energy radiation in the visible light spectrum, was recently reported to
induce skin pigmentation. In this study, we investigated the involvement of TRPV1-mediated …
induce skin pigmentation. In this study, we investigated the involvement of TRPV1-mediated …
Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy
Clusterin (CLU) is an evolutionary conserved molecular chaperone present in different
human tissues and fluids and established to be a significant cancer regulator. It controls …
human tissues and fluids and established to be a significant cancer regulator. It controls …
Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease
Y Zhou, I Hayashi, J Wong, K Tugusheva, JJ Renger… - PloS one, 2014 - journals.plos.org
Sporadic or late-onset Alzheimer's disease (AD) is expected to affect 50% of individuals
reaching 85 years of age. The most significant genetic risk factor for late-onset AD is the e4 …
reaching 85 years of age. The most significant genetic risk factor for late-onset AD is the e4 …